Today in News History

On July 12, several notable moments in the history of News stand out. In 1754, Thomas Bowdler, English physician and philanthropist (died 1825) was born. In 1899, Fiat founded by Giovanni Agnelli in Turin, Italy. In 1944, Michael Levy, Baron Levy, English philanthropist was born. In 1986, Ryan Jarvis, English footballer was born. In 1993, Rebecca Bross, American gymnast was born. In 1995, Tyler Medeiros, Canadian singer-songwriter and dancer was born. In 2007, Ed Mirvish, American-Canadian businessman and philanthropist, founded Honest Ed's (born 1914) passed away. In 2008, Michael E. DeBakey, American surgeon and educator (born 1908) passed away. In 2013, Emik Avakian, Iranian-American inventor (born 1923) passed away. In 2015, André Leysen, Belgian businessman (born 1927) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

Novartis buys UK biotech Myricx for up to $1.5bn to chase a new cancer-drug class

The Next Web

The Next Web

·

July 6, 2026

·

lean left
Novartis buys UK biotech Myricx for up to $1.5bn to chase a new cancer-drug class

Novartis has agreed to buy Myricx Bio, a small British oncology company, for up to 1.5bn, adding an early-stage but potentially significant technology to a cancer pipeline the industry keeps racing to expand. The Swiss group will pay 1.1bn upfront, with up to 400m more tied to milestones, in a deal that fits the pattern [] This story continues at The Next Web

Narrative Intelligence Brief

This article was published by The Next Web, a source frequently categorized with a lean left bias based in Netherlands. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The Next Web, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 4 related reports from 4 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

4 sources

Left 50%

Center 25%

Right 25%


Topics:

Business · 3
Technology · 1

Related coverage for "Novartis buys UK biotech Myricx for up to $1.5bn to chase a new cancer-drug class": Seeking Alpha — Micron At $1,750 Is Now My Base Case. The Next Web — Astral Systems raises £23M to make cancer isotopes by fusion. The Motley Fool — SpaceX Stock Just Received Its Highest Price Target Yet. Here's What a $10,000 Investment Would Be Worth if This Insanely Bullish Wall Street Analyst Is Right.. Investopedia — SpaceX Stock Finished in the Green Today—But It Hasn't Gained Much Since Its IPO Two Weeks Ago